Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Calyxt Inc | CLXT | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
6.30 |
Trades | Shares Traded | Average Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 2.64 - 7.77 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
- | 0 | US$ 6.30 | USD |
Calyxt Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
US$ 31.33M | - | - | - | -580.27 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Calyxt News
Date | Time | Source | News Article |
---|---|---|---|
4/19/2024 | 15:10 | Edgar (US Regulatory) | Form ARS - Annual Report to Security Holders |
4/19/2024 | 15:08 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting.. |
4/19/2024 | 15:06 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
3/21/2024 | 15:52 | Edgar (US Regulatory) | Form 8-K - Current report |
3/21/2024 | 15:07 | Edgar (US Regulatory) | Form 8-K - Current report |
3/08/2024 | 16:01 | Edgar (US Regulatory) | Form 8-K - Current report |
1/09/2024 | 15:47 | Edgar (US Regulatory) | Form 8-K - Current report |
1/02/2024 | 06:15 | Edgar (US Regulatory) | Form 8-K - Current report |
1/02/2024 | 06:07 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
12/29/2023 | 15:35 | Edgar (US Regulatory) | Form 8-K - Current report |
12/14/2023 | 10:23 | Edgar (US Regulatory) | Form 8-K - Current report |
12/12/2023 | 07:01 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CLXT Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Year | 2.94 | 7.77 | 2.64 | 4.61 | 66,986 | 3.36 | 114.29% |
3 Years | 51.20 | 54.185 | 1.25 | 7.78 | 619,116 | -44.90 | -87.70% |
5 Years | 164.60 | 165.10 | 1.25 | 18.19 | 383,034 | -158.30 | -96.17% |
Calyxt Description
Calyxt Inc is a plant-based synthetic biology company. The company leverages its proprietary PlantSpring technology platform to engineer plant metabolism to produce innovative high value plant-based chemistries for use in customers' materials and products. As plant-based solutions, the company's synthetic biology products can be used in helping customers meet sustainability targets and financial goals. The company's diversified offerings are primarily delivered through its proprietary BioFactory production system. |